Stock ledger
$BRVE Insider Trading
Braveheart Bio, Inc.
5
Alerts Sent
75%
Hit Rate Here
0
Insider Buys 30d
0
Insider Sells 30d
This page is InsiderWatch’s own record for BRVE: every alert we sent on this stock, scored against real market prices, plus recent insider buying and selling reported to the SEC on Form 4.
Price and Our Alerts
$BRVE price
Daily closing prices
3M change
-2.0%
1Y high
$30.00
1Y low
$25.01
Our alerts
5
in this window
Prices from public market data and may be delayed. Markers show the days our alerts on this stock fired. Not investment advice.
Our Alerts on $BRVE
| Sent (ET) | Call | Alert | Result |
|---|---|---|---|
| Sep 10, 5:08 PM | BEARISH | OrbiMed cuts Braveheart Bio stake to 13.5% | -2.0% ✓ hit |
| Aug 18, 5:01 PM | BULLISH | OrbiMed discloses 17.2% stake in Braveheart Bio | +8.3% ✓ hit |
| Aug 14, 4:56 PM | BULLISH | AH Bio Fund takes 11.4% stake in Braveheart Bio | +7.2% ✓ hit |
| Aug 11, 5:28 PM | BULLISH | OrbiMed, insiders buy $104M of new IPO Braveheart Bio | +15.8% ✓ hit |
| Aug 7, 4:32 PM | BULLISH | Braveheart Bio director buys $1M of stock | -16.6% ✗ miss |
Every alert we sent on BRVE is listed once scored, hits and misses alike. Result is the stock’s move from the alert to the graded exit of its catalyst window.
Recent Insider Activity
Open-market buys and sells in BRVE by the company’s own officers, directors, and large holders, as reported to the SEC on Form 4 in roughly the last 30 days. New to the filing? Read what a Form 4 is and what the transaction codes mean.
| Filed (ET) | Insider | Action | Value |
|---|---|---|---|
| Aug 11 | AH Bio Fund IV, L.P.10% owner | BUY | $19.8M |
| Aug 11 | AH Equity Partners Bio IV, L.L.C.10% owner | BUY | $19.8M |
| Aug 11 | Andreessen Marc L10% owner | BUY | $19.8M |
| Aug 11 | HOROWITZ BENJAMIN A10% owner | BUY | $19.8M |
| Aug 11 | Chimovits ErezDirector | BUY | $34.9M |
| Aug 11 | ORBIMED ADVISORS LLCDirector | BUY | $34.9M |
| Aug 11 | OrbiMed Capital GP IX LLCDirector | BUY | $34.9M |
| Aug 11 | OrbiMed Genesis GP LLCDirector | BUY | $34.9M |
| Aug 7 | Forbion Growth Opportunities Fund III Cooperatief U.A.10% owner | BUY | $64.8M |
| Aug 7 | Forbion Growth III Management B.V.10% owner | BUY | $64.8M |
| Aug 7 | Forbion Ventures Fund VII Cooperatief U.A.10% owner | BUY | $64.8M |
| Aug 7 | Forbion Ventures VII Management B.V.10% owner | BUY | $64.8M |
| Aug 7 | Rickey James PaulChief Financial Officer | BUY | $500k |
| Aug 7 | Viehbacher ChristopherDirector | BUY | $1.5M |
| Aug 7 | Malek David IDirector | BUY | $75k |
| Aug 7 | Murdoch TravisCEO and President | BUY | $1.5M |
| Aug 7 | Lubner David CharlesDirector | BUY | $1000k |
Sourced from public SEC Form 4 filings. Buys shown are open-market purchases; routine grants and plan sales are filtered out before a trade reaches this log.
See the latest alerts across all stocks, the complete scored track record, this week’s insider buying, or the congress trading tracker.
Get the Next BRVE Alert When It Fires.
Everything here is already graded and public. Subscribers got it the minute it fired. Pro members get every alert; Watchlist members get the ones on stocks they follow. Free for 7 days, cancel any time.
Try Free for 7 DaysPast performance is not indicative of future results. Directional scoring measures a catalyst-matched window on daily closing prices and does not reflect fees, slippage, taxes, or execution. InsiderWatch is an informational service based on publicly available information only and is not financial, investment, legal, or tax advice. Outcomes are scored automatically against public market data by our own systems and are not independently audited.